semaglutide and ibd versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial GLP-1 receptor agonists in IBD:

Brain 140, 21122119

QoL improved according to narrative reports, and the increases in FS, SCS, and RRM were significantly higher than the meaningful threshold, ranging from 2-fold (RRM 31-40) to 3-fold (FS 39-48) to 20-fold (SCS 27-36) above baseline ( Figure 3 )

Fakhri S, Yosifova Aneva I, Farzaei MH, Sobarzo-Snchez E (2019) The neuroprotective effects of astaxanthin: therapeutic targets and clinical perspective

With regular use, it supports smoother, softer, and healthier-looking skin while helping maintain a radiant and youthful glow

BPC-157 has extensive animal data for both gastrointestinal and neurological effects but lacks published large-scale human clinical trials for depression specifically

According to clinical guidelines, GLP-1 receptor agonists are generally added to a type 2 diabetes treatment plan if you: 1